Accolade (ACCD) Stock Price, News & Analysis

Company Overview

Accolade, Inc. (NASDAQ: ACCD) is a healthcare technology company that offers personalized health and benefits solutions designed to improve consumer experience and optimize healthcare outcomes. The company’s cloud-based platform combines advanced data analytics, digital tools, and dedicated healthcare professionals to guide individuals through complex healthcare and benefits decisions. Accolade’s core services include personalized health assistance, virtual care coordination, benefits navigation, and condition management, all delivered through a single integrated digital experience.

Founded in 2007 and headquartered in Seattle, Washington, Accolade has expanded its presence across the United States and into international markets, including the United Kingdom. The company partners primarily with large employers, health plans, and brokerages to deliver its services to millions of members and employees. By leveraging proprietary technology and a network of nurse advocates, health assistants and specialists, Accolade aims to reduce the friction often associated with accessing care and to drive better clinical and financial outcomes for its clients.

Throughout its history, Accolade has focused on innovation in consumer engagement and care navigation. Its digital platform integrates with electronic health records (EHRs), pharmacy benefit management systems, and other healthcare data sources to provide real-time insights and personalized recommendations. These integrations enable Accolade’s care teams to proactively identify high-risk individuals, streamline care pathways, and facilitate seamless communication between patients, providers, and payers.

Leadership at Accolade includes co-founder and Chief Executive Officer Rajeev Singh, who has guided the company’s growth and product development since its inception. Under his direction, Accolade has assembled an experienced management team with deep expertise in healthcare, technology, and benefits administration. As the healthcare landscape continues to evolve, Accolade remains focused on delivering consumer-centric solutions that enhance access to care, improve member satisfaction, and drive value for its clients.

Key Stats

• Today's Range: $7.02 to $7.02
• 50-Day Range: $7.02 to $7.02
• 52-Week Range: $3.08 to $7.03
• Volume: N/A
• Average Volume: 1.51 million shs
• Market Capitalization: $575.59 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.57
• Consensus Rating: Hold

Accolade Stock Analysis - MarketRank™

Accolade scored higher than 19% of companies evaluated by MarketBeat, and ranked 253rd out of 304 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Accolade has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 13 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Accolade has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Accolade are expected to grow in the coming year, from ($1.20) to ($0.86) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Accolade is -3.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Accolade is -3.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Accolade has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for ACCD.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Accolade does not currently pay a dividend.

Dividend Growth

Accolade does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.8 / 5
• Environmental Score: -0.89

Short Interest

There is no current short interest data available for ACCD.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Accolade insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 8.20% of the stock of Accolade is held by insiders.

Percentage Held by Institutions

84.99% of the stock of Accolade is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ACCD Stock Analysis - Frequently Asked Questions

How have ACCD shares performed this year?

Accolade's stock was trading at $3.42 at the start of the year. Since then, ACCD stock has increased by 105.3% and is now trading at $7.02.

How were Accolade's earnings last quarter?

Accolade, Inc. (NASDAQ:ACCD) posted its quarterly earnings results on Friday, January, 10th. The company reported ($0.30) EPS for the quarter, topping analysts' consensus estimates of ($0.31) by $0.01. Accolade had a negative trailing twelve-month return on equity of 20.74% and a negative net margin of 40.36%.

When did Accolade IPO?

Accolade (ACCD) raised $176 million in an initial public offering (IPO) on Thursday, July 2nd 2020. The company issued 8,800,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, Morgan Stanley and BofA Securities served as the underwriters for the IPO and Piper Sandler, Credit Suisse, William Blair, Baird and SVB Leerink were co-managers.

How do I buy shares of Accolade?

Shares of ACCD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Accolade own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Accolade investors own include American Water Works (AWK), Waste Connections (WCN), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), Humana (HUM), The RMR Group (RMR) and iShares Micro-Cap ETF (IWC).

Company Calendar

• Last Earnings: 1/10/2025
• Today: 7/10/2025
• Fiscal Year End: 2/28/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Business services, not elsewhere classified
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:ACCD
• CIK: 1481646
• Web: accolade.com
• Phone: 206-926-8100
• Fax: N/A
• Employees: 2,350
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Accolade: $6.57
• High Price Target: $8.00
• Low Price Target: $5.00
• Potential Upside/Downside: -6.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 13 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.25)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$99.81 million
• Net Margins: -40.36%
• Pretax Margin: -39.96%
• Return on Equity: -20.74%
• Return on Assets: -11.33%

Debt

• Debt-to-Equity Ratio: 0.67
• Current Ratio: 2.63
• Quick Ratio: 2.63

Sales & Book Value

• Annual Sales: $446.72 million
• Price / Sales: 1.29
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $5.75 per share
• Price / Book: 1.22

Miscellaneous

• Outstanding Shares: 81,993,000
• Free Float: 74,896,000
• Market Cap: $575.59 million
• Optionable: Optionable
• Beta: 2.10